Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9485008)

  • 1. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
    Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
    Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Ichimura K; Bolin MB; Goike HM; Schmidt EE; Moshref A; Collins VP
    Cancer Res; 2000 Jan; 60(2):417-24. PubMed ID: 10667596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
    Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
    Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
    Reifenberger G; Liu L; Ichimura K; Schmidt EE; Collins VP
    Cancer Res; 1993 Jun; 53(12):2736-9. PubMed ID: 8504413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement.
    Hori M; Shimazaki J; Inagawa S; Itabashi M; Hori M
    Pathol Int; 2000 Oct; 50(10):786-92. PubMed ID: 11107050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines.
    Weng MW; Lai JC; Hsu CP; Yu KY; Chen CY; Lin TS; Lai WW; Lee H; Ko JL
    Environ Mol Mutagen; 2005 Jul; 46(1):1-11. PubMed ID: 15714438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines.
    Bartel F; Taylor AC; Taubert H; Harris LC
    Oncol Res; 2001; 12(11-12):451-7. PubMed ID: 11939408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.
    Bartel F; Pinkert D; Fiedler W; Kappler M; Würl P; Schmidt H; Taubert H
    Int J Oncol; 2004 Jan; 24(1):143-51. PubMed ID: 14654951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.
    Liang H; Atkins H; Abdel-Fattah R; Jones SN; Lunec J
    Gene; 2004 Sep; 338(2):217-23. PubMed ID: 15315825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.
    Sigalas I; Calvert AH; Anderson JJ; Neal DE; Lunec J
    Nat Med; 1996 Aug; 2(8):912-7. PubMed ID: 8705862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.
    Bartel F; Meye A; Würl P; Kappler M; Bache M; Lautenschläger C; Grünbaum U; Schmidt H; Taubert H
    Int J Cancer; 2001 May; 95(3):168-75. PubMed ID: 11307150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor promotion by Mdm2 splice variants unable to bind p53.
    Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
    Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of wild type p53 protein in human astrocytomas.
    Rubio MP; von Deimling A; Yandell DW; Wiestler OD; Gusella JF; Louis DN
    Cancer Res; 1993 Aug; 53(15):3465-7. PubMed ID: 8339248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
    Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.
    Tamborini E; Della Torre G; Lavarino C; Azzarelli A; Carpinelli P; Pierotti MA; Pilotti S
    Int J Cancer; 2001 Jun; 92(6):790-6. PubMed ID: 11351297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.
    Biernat W; Kleihues P; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):180-5. PubMed ID: 9034372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MDM2 during mammary tumorigenesis.
    Pinkas J; Naber SP; Butel JS; Medina D; Jerry DJ
    Int J Cancer; 1999 Apr; 81(2):292-8. PubMed ID: 10188733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
    Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
    Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.